Cars - cysteinyl-tRNA synthetase Gene
Also Known as CA3; Cars1
Species: Mus musculus
Gene Type: protein coding
Gene ID: 27267
Summary
Predicted to enable several functions, including ATP binding activity; cysteine-tRNA Ligase activity; and protein homodimerization activity. Predicted to be involved in cysteinyl-tRNA aminoacylation. Predicted to act upstream of or within translation. Predicted to be located in cytosol. Predicted to be active in cytoplasm. Is expressed in several structures, including alimentary system; genitourinary system; integumental system; nervous system; and sensory organ. Orthologous to human CARS1 (cysteinyl-tRNA synthetase 1). [provided by Alliance of Genome Resources, Apr 2022]
Cars Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001252593.1 | NP_001239522.1 | cysteine--tRNA ligase, cytoplasmic isoform 2 |
| NM_013742.5 | NP_038770.3 | cysteine--tRNA ligase, cytoplasmic isoform 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cysteine--tRNA ligase, cytoplasmic |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0488A | Vincristine | 98.60% | Yes | |
| HY-70037 | Cinacalcet | Agonist | 99.93% | Yes |
| HY-70037A | Cinacalcet hydrochloride | Agonist | 99.98% | Yes |
| HY-B0349 | Meclizine dihydrochloride | 99.95% | Unkown | |
| HY-157959 | Orphenadrine | 99.71% | Unkown | |
| HY-B0349A | Meclizine | / | Unkown | |
| HY-B0349B | Meclizine dihydrochloride monohydrate | / | Unkown |
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-159649 | BMS-986408 | 99.35% | Phase 2 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99157 | Omburtamab | Inhibitor | 99.16% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(63)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-163028 | ML-T7 | 99.93% | Unkown | |
| HY-103244 | CITCO | Inducer | 99.60% | Unkown |
| HY-103243 | TCPOBOP | Inhibitor | 99.70% | Unkown |
| HY-112171 | γ-L-Glutamyl-L-alanine | Modulator | 98.0% | Unkown |
| HY-119459 | Fluopyram | 99.76% | Unkown | |
| HY-153084A | CD19 CAR mRNA (Human) | / | Unkown | |
| HY-110249 | CINPA1 | 99.80% | Unkown | |
| HY-155978A | RDN2150 TFA | Inhibitor | 99.80% | Unkown |
| HY-131911 | PROTAC IDO1 Degrader-1 | Inhibitor | 99.00% | Unkown |
| HY-144987 | RBN013209 | Inhibitor | 98.63% | Unkown |
| HY-148495 | Carnosine conjugated hyalyronate | Inhibitor | 90.0% | Unkown |
| HY-W008583 | Bis(4-tert-butylphenyl)amine | / | Unkown | |
| HY-N1457 | Chrysosplenetin | 99.84% | Unkown | |
| HY-W013854 | 5α-Androstan-3β-ol | 98.00% | Unkown | |
| HY-112171R | γ-L-Glutamyl-L-alanine (Standard) | Modulator | 99.29% | Unkown |
| HY-145534 | trans-2-Octenoyl-L-carnitine | 99.92% | Unkown | |
| HY-146231A | SS47 TFA | Inhibitor | 99.88% | Unkown |
| HY-RS01933 | CARS1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W015026 | Isobutylparaben | 98.87% | Unkown | |
| HY-W101305 | Fmoc-Pen(Acm)-OH | / | Unkown | |
| HY-111634 | Epsilon-momfluorothrin | 99.76% | Unkown | |
| HY-15105 | SB-423562 | Antagonist | 99.66% | Unkown |
| HY-155978 | RDN2150 | Inhibitor | / | Unkown |
| HY-173033 | MI-883 | 99.57% | Unkown | |
| HY-180888 | Lck-IN-5 | Inhibitor | 98.09% | Unkown |
| HY-183912 | PY-4Car2 | Inhibitor | / | Unkown |
| HY-156199 | o-Cresol sulfate | 98.13% | Unkown | |
| HY-70037AS | Cinacalcet-d3 hydrochloride | Agonist | 97.63% | Unkown |
| HY-185002 | BCMA CAR mRNA | / | Unkown | |
| HY-117774 | AHR-2244 hydrochloride | / | Unkown | |
| HY-135601 | Cinacalcet metabolite M4 | / | Unkown | |
| HY-139678 | SC13 | / | Unkown | |
| HY-15106 | SB-423557 | Antagonist | / | Unkown |
| HY-153085 | CD19 CAR circRNA | / | Unkown | |
| HY-155295 | Z-CITCO | Agonist | / | Unkown |
| HY-160151 | TP1L | / | Unkown | |
| HY-174418 | NM600 | / | Unkown | |
| HY-70037S | Cinacalcet-d3 | Agonist | / | Unkown |
| HY-B0349S | Meclizine-d8 | / | Unkown | |
| HY-B1380A | Carisoprodol/BSA | / | Unkown | |
| HY-D2620 | CAR-2 | Inducer | / | Unkown |
| HY-P10417 | RTDLDSLRTYTL | Inhibitor | / | Unkown |
| HY-P10417B | RTDLDSLRTYTL TFA | Inhibitor | / | Unkown |
| HY-RS01905 | Car1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01906 | Car1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01907 | Car12 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01908 | Car12 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01909 | Car2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01910 | Car2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01911 | Car4 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01912 | Car4 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01913 | Car9 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01914 | Car9 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01934 | CARS2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W015026R | Isobutylparaben (Standard) | / | Unkown | |
| HY-W015026S | Isobutylparaben-d4 | 98.5% | Unkown | |
| HY-W709413 | Panaxytriol | / | Unkown | |
| HY-W722556 | 5α-Androstan-3α-ol | / | Unkown | |
| HY-157288 | (R)-Phe-A110/B319 | / | Unkown | |
| HY-182543 | NPS-467 | Activator | / | Unkown |
| HY-RS22414 | Cars2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28937 | Cars2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W653978 | Cinacalcet-d4 hydrochloride | Agonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990245 | Anti-Mouse FAP Antibody (73.3) | Inhibitor | 95.00% | Unkown |
| HY-P990870 | Anti-CD19 Antibody (4G7) | Inhibitor | 98% | Unkown |
| HY-P992178 | ALLO-647 | / | Unkown | |
| HY-P992338 | CT-1119 | Inhibitor | / | Unkown |